CAS: 16404-54-9; (R)-4-Methylpentan-2-Ol

相似化合物

14898-80-7 51079-52-8 627-59-8

欧盟法规

[ECHA物质

上下游产品

CAS号108-10-1 甲基异丁基甲酮 | CAS号625-28-5 异戊腈 | CAS号80422-47-5 2-tert-butyl-8-... | CAS号80422-50-0 (SS)-4-methyl-1... | CAS号108-11-2 甲基异丁基甲醇(MIBC) | CAS号674-76-0 1-丁基环己醇 | CAS号920-39-8 异丙基溴化镁 | CAS号74669-70-8 (R)-2,3-Dimethy...

4-甲基-2-戊醇 反应生成(R)-(-)-4-甲基-2-戊醇
参考文献:通过胆酰胺包合物的氢键"双钩"拆分脂肪醇
标题:通过胆酰胺包合物的氢键"双钩"拆分脂肪醇
摘要:研究了用胆酰胺(3α,7α,12α-三羟基-5β-胆烷-24-酰胺)的包合方法拆分脂肪醇的方法.
Doi:10.1016/0957-4166(95)00349-T

专利信息

专利号:US-2024294532-A1
优先权日:2021-07-12
标题 :Synthesis of chiral substituted pyrazolopyrimidine compounds
发明人：TOMAS LOÃ?C; HARRIS CRAIG STEVEN
权利人:GALDERMA HOLDING S A
摘要:The present invention relates to processes and intermediates for the preparation of compounds useful as inhibitors of mechanistic target of rapamycin (mTOR).

专利号:EP-4370517-A1
优先权日:2021-07-12
标题 :Synthesis of chiral substituted pyrazolopyrimidine compounds

专利号:WO-2023285926-A1
优先权日:2021-07-12
标题 :Synthesis of chiral substituted pyrazolopyrimidine compounds

专利号:US-9328073-B2
优先权日:2011-05-25
标 题 :Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase I inhibitors
发明人：CUSHMAN MARK S; POMMIER YVES GEORGE
权利人:CUSHMAN MARK S; POMMIER YVES GEORGE; PURDUE RESEARCH FOUNDATION
摘要:The invention described herein pertains to substituted indenoisoquinoline compounds as described herein, wherein R A , R D , W, X and Y are defined herein, pharmaceutical compositions and formulations comprising the indenoisoquinoline compounds, their synthesis, and methods for their use in the treatment and/or prevention of cancer.

专利号:US-9682990-B2
优先权日:2011-05-25
标 题 :Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase I inhibitors
发明人：CUSHMAN MARK STANLEY; BECK DANIEL EDWARD
权利人:PURDUE RESEARCH FOUNDATION
摘要:The invention described herein pertains to substituted indenoisoquinoline compounds as described herein, wherein R A , R D , W, X and Y are defined herein, pharmaceutical compositions and formulations comprising the indenoisoquinoline compounds, their synthesis, and methods for their use in the treatment and/or prevention of cancer.